Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas

Cancer Letters

Volumn 148, Issue 2, 2000, Pages 127-134

  Kataoka, Hiroaki ^a   Itoh, Hiroshi ^a   Uchino, Hirofumi ^a   Hamasuna, Ryouichi ^a   Kitamura, Naomi ^b   Nabeshima, Kazuki ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Colon carcinoma; Hepatocyte growth factor activator; Hepatocyte growth factor activator inhibitor type 2; Placental bikunin

Indexed keywords

INHIBITOR PROTEIN; SCATTER FACTOR; ULINASTATIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL DIFFERENTIATION; COLON; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TRYPSIN INHIBITOR, KUNITZ SOYBEAN;

ANIMALIA;

EID: 0033980346     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00322-5     Document Type: Article

References (28)

1. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81:1988;414-419.
2. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:1987;311-316.
3. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
4. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y., Birchmeier W. Evidence for the identity of human scatter factor and human growth factor. Proc. Natl. Acad. Sci. USA. 88:1991;7001-7005.
5. Naldini L., Weidner K.M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R.P., Hartmann G., Zarnegar R., Michalopoulos W., Birchmeier W., Comoglio P.M. Scatter factor and Hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10:1991;2867-2878.
6. Naka D., Ishii T., Yoshiyama Y., Miyazawa K., Hara H., Hishida T., Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of single chain form to a heterodimer. J. Biol. Chem. 267:1992;20114-20119.
7. Shimomura T., Ochiai M., Kondo J., Morimoto Y. A novel protease obtained from FBS-containing culture supernatant, that processes single-chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology. 8:1992;219-229.
8. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268:1993;10024-10028.
9. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem. 229:1995;257-261.
10. Miyazawa K., Shimomura T., Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 271:1996;3615-3618.
11. Shimomura T., Kondo J., Ochiai M., Naka D., Miyazawa K., Morimoto Y., Kitamura N. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J. Biol. Chem. 268:1993;22927-22932.
12. Miyazawa K., Shimomura T., Naka D., Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 269:1994;8966-8970.
13. Shimomura T., Denda K., Kitamura A., Kawaguchi T., Kito M., Kondo J., Kagaya S., Qin L., Takata H., Miyazawa K., Kitamura N. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:1997;6370-6376.
14. Kawaguchi T., Qin L., Shimomura T., Kondo J., Matsumoto K., Denda K., Kitamura N. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:1997;27558-27564.
15. Marlor C.W., Delaria K.A., Davis G., Muller D.K., Greve J.M., Tamburini P.P. Identification and cloning of human placenta bikunin, a novel serine protease inhibitor containing two Kunitz domains. J. Biol. Chem. 272:1997;12202-12208.
16. Müller-Pillasch F., Wallrapp C., Bartels K., Varga G., Friess H., Büchler M., Adler G., Gress T.M. Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer. Biochim. Biophys. Acta. 1395:1998;88-95.
17. Delaria K.A., Muller D.K., Marlor C.W., Brown J.E., Das R.C., Roczniak S.O., Tamburini P.P. Characterization of placental bikunin, a novel human serine protease inhibitor. J. Biol. Chem. 272:1997;12209-12214.
18. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thiery J.-P., Jouanneau J. Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene. 9:1994;1091-1099.
19. Rong S., Segal S., Anver M., Resau J.H., Vande Woude G.F. Invasiveness and metastasis of NIH3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA. 91:1994;4731-4735.
20. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 119:1996;591-600.
21. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57:1997;3305-3313.
22. Liu C., Park M., Tsao M.S. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene. 7:1992;181-185.
23. Kataoka H., Uchino H., Denda K., Kitamura N., Itoh H., Tsubouchi H., Nabeshima K., Koono M. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett. 128:1998;219-227.
24. Kataoka H., Suganuma T., Shimomura T., Itoh H., Kitamura N., Nabeshima K., Koono M. Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47:1999;673-682.
25. Qin L., Denda K., Shimomura T., Kawaguchi T., Kitamura N. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. FEBS Lett. 436:1998;111-114.
26. Itoh H., Kataoka H., Hamasuna R., Kitamura N., Koono M. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Biochem. Biophys. Res. Commun. 255:1999;740-748.
27. Nakamura T., Asami O., Tanaka K., Ichihara A. Increased survival of rat hepatocytes in serum-free medium by inhibition of trypsin-like protease associated with their plasma membranes. Exp. Cell Res. 154:1984;81-91.
28. McKeehan W.L., Sakagami Y., Hoshi H., McKeehan K.A. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J. Biol. Chem. 261:1986;5378-5383.